Gilead Sciences
GILD
#100
Rank
A$259.75 B
Marketcap
A$209.34
Share price
2.06%
Change (1 day)
35.44%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): A$15.32 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$29.08 Billion. In 2024 the company made an earning of A$0.98 Billion a decrease over its 2023 earnings that were of A$9.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$15.32 B1451.53%
2024 A$0.98 B-89.94%
2023 A$9.81 B17.97%
2022 A$8.32 B-29.77%
2021 A$11.85 B395.99%
2020 A$2.38 B-67.66%
2019 A$7.38 B-33.84%
2018 A$11.16 B-42.35%
2017 A$19.36 B-20.87%
2016 A$24.47 B-21.06%
2015 A$31.00 B45.8%
2014 A$21.26 B253.01%
2013 A$6.02 B16.51%
2012 A$5.17 B-1.07%
2011 A$5.22 B-6.71%
2010 A$5.60 B11.75%
2009 A$5.01 B29.5%
2008 A$3.87 B19.11%
2007 A$3.25 B-455.74%
2006 -A$0.92 Billion-154.93%
2005 A$1.66 B76.99%
2004 A$0.93 B-266.16%
2003 -A$0.57 Billion-638.24%
2002 A$0.10 B31.5%
2001 A$79.9 M-242.15%
2000 -A$56.22 Million-40.2%
1999 -A$94.01 Million31.85%
1998 -A$71.3 Million8.73%
1997 -A$65.57 Million27.22%
1996 -A$51.54 Million
1994 -A$49.11 Million26.57%
1993 -A$38.8 Million46.49%
1992 -A$26.49 Million362.5%
1991 -A$5.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.37 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$16.96 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.37 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.21 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.80 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.72 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.42 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.38 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$33.05 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA